drugset
drugset / Trial / NCT03126539

Effect of Topical Sulforaphane on Skin Fragility Seen in Skin Aging and With Ultraviolet Exposure

NCT03126539 ↗

Phase 2 Terminated 9 enrolled Johns Hopkins University
RandomizedParallel-groupOpen-labelOther

Summary

This study aims to compare the expression of keratins before and after application of sulforaphane (SF) to determine whether this agent alters skin fragility seen in both intrinsic and extrinsic skin aging and UV light exposure.

Timeline

Start
2017-09-15
Primary completion
2019-01-18
Completion
2019-01-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Sulforaphane Small molecule — Topical

Indications

No indication recorded.